You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 9, September 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neurogenetics
 •Neuromuscular diseases
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Two Novel Mitochondrial DNA Mutations in Muscle Tissue of a Patient With Limb-Girdle Myopathy

Ann Meulemans, MSc; Boel De Paepe, PhD; Jan De Bleecker, MD, PhD; Joél Smet, BSc; Willy Lissens, PhD; Rudy Van Coster, MD, PhD; Linda De Meirleir, MD, PhD; Sara Seneca, PhD

Arch Neurol. 2007;64(9):1339-1343.

Background  Defects in the oxidative phosphorylation system can cause a broad spectrum of clinical symptoms ranging from an isolated myopathy to a multisystemic disorder.

Objective  To study and identify the underlying molecular defect in a patient with limb-girdle myopathy.

Design  Biochemical, histochemical, and immunocytochemical analyses were performed in combination with polymerase chain reaction–single-strand conformation polymorphism and restriction fragment length polymorphism–polymerase chain reaction techniques.

Setting  University hospital.

Patient  A 48-year-old woman with limb-girdle myopathy.

Main Outcome Measures  The pathogenic characteristics of the identified nucleotide alterations were defined using single-muscle fiber analysis.

Results  A complex III deficiency was detected using blue native–polyacrylamide gel electrophoresis, while immunocytochemical results showed a mosaic staining pattern for complexes I and IV. After molecular analyses, 2 novel heteroplasmic mitochondrial DNA (mtDNA) nucleotide aberrations, m.5888insA and m.14639A>G, were identified in muscle tissue. Single-muscle fiber analyses demonstrated that cytochrome c oxidase–deficient fibers, compared with cytochrome c oxidase–positive fibers, harbored statistically significantly higher levels of both mtDNA mutations (P < .001, t test).

Conclusions  These results, together with previously defined canonical criteria determining the pathogenic characteristics of mtDNA mutations, suggest that both nucleotide changes are pathogenic mutations. To our knowledge, this is only the third report of the coexistence of 2 pathogenic mtDNA mutations present in different genes within individual skeletal muscle fibers of a patient.


Author Affiliations: Center for Medical Genetics (Ms Meulemans and Drs Lissens and Seneca) and Department of Pediatric Neurology Universitair Ziekenhous Brussel (UZ Brussel) (Dr De Meirleir), Vrije Universiteit Brussel, Brussels, and Departments of Neurology (Drs De Paepe and De Bleecker) and Pediatric Neurology and Metabolism Service (Drs De Paepe and Van Coster and Mr Smet), Ghent University Hospital, Ghent, Belgium.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects
De Paepe et al.
J. Clin. Pathol. 2009;62:172-176.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.